SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse Frankfurt
Börse Börse Frankfurt
ISIN US4781601046
EUR
  • Johnson & Johnson
    Börse Börse Frankfurt
    ISIN US4781601046
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse Stuttgart
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse München
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse Berlin
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Xetra Frankfurt
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Gettex System der Börse München
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Quotrix System der Börse Düsseldorf
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Börse Düsseldorf
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Börse Hamburg
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse SGO
    USD
  • Johnson & Johnson
    Börse BUE
    USD
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
  • Johnson & Johnson
    Börse SSE
ISIN US4781601046
Symbol JNJ
Währung EUR
Börse Börse Frankfurt Zeitzone: Europe/Berlin
Marktkapitalisierung 99.567.000.000
Mitarbeiter 141.700

Zahlte zuletzt am 25.05.2021 eine Dividende von 1,06 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Die Dividendenrendite entsprach 14,66 % p. a. beim aktuellen Kurs von 137,58 EUR +0,02% 

Analystenmeinungen

Übersicht

Aktionärsstruktur der Johnson & Johnson

2.994 News & Informationen zur Johnson & Johnson Aktie

  • Video
    Investflow

  • Video
    Homo Oeconomicus

  • Video
    Investflow

  • FirstFT: Global stocks rebound from Evergrande-induced crisis
    ft.com

    FirstFT: Global stocks rebound from Evergrande-induced crisis

    Chinese policymakers expected act to prevent Evergrande crisis, IEA urges Russia to ramp up gas supply to Europe, UK weighs joining USMCA

  • Hedge Funds Have Never Been This Bullish On Berkshire Hathaway (BRK.B)
    insidermonkey.com

    Hedge Funds Have Never Been This Bullish On Berkshire Hathaway (BRK.B)

    Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.

  • China's Evergrande crisis could drag down Tether and other cryptocurrencies: CNBC After Hours
    cnbc.com

    China's Evergrande crisis could drag down Tether and other cryptocurrencies: CNBC After Hours

    On today's show, CNBC's Kate Rooney explains why Chinese property developer Evergrande's debt crisis could be trouble for Tether.

  • Tennessee says vaccinated people should be last in line for antibody treatments to save them for the unvaccinated
    businessinsider.com

    Tennessee says vaccinated people should be last in line for antibody treatments to save them for the unvaccinated

    Unvaccinated residents of Tennessee are being prioritized for the treatment because they're more vulnerable to severe COVID-19.

  • Alibaba Group Holding Limited (BABA): Are Hedge Funds Right About This Stock?
    insidermonkey.com

    Alibaba Group Holding Limited (BABA): Are Hedge Funds Right About This Stock?

    The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database.

  • Johnson & Johnson says Covid-19 booster shot is 94% effective
    business-standard.com

    Johnson & Johnson says Covid-19 booster shot is 94% effective

    Read more about Johnson & Johnson says Covid-19 booster shot is 94% effective on Business Standard. J&J said a booster given two months after the first dose increased antibody levels four to six-fold

  • Worldwide Medical Equipment Maintenance Industry to 2026 - Growth in Medical Tourism Presents Opportunities
    prnewswire.com

    Worldwide Medical Equipment Maintenance Industry to 2026 – Growth in Medical Tourism Presents Opportunities

    /PRNewswire/ — The “Medical Equipment Maintenance Market Research Report by Device Type, by Service Provider, by Service Type, by Region – Global Forecast to…

  • After a wobbly day, major indexes end mixed on Wall Street
    startribune.com

    After a wobbly day, major indexes end mixed on Wall Street

    Major indexes ended mixed on Wall Street Tuesday after spending much of the day wobbling between gains and losses. For parts of the afternoon the market had looked like it would recoup some of the losses it took in a big pullack a day earlier, but by the closing bell even those gains had mostly fizzled. The S&P 500 ended down a bit less than 0.1%, and the Dow Jones Industrial Average fell 0.1%. Gains for some tech companies helped nudge the Nasdaq up 0.2%. Uber jumped 11.5% after raising its outlook. The yield on the 10-year Treasury edged up to 1.32%.

  • S&P 500 Ends Lower as China-led Global Growth Worries Persist; Fed Eyed By Investing.com
    investing.com

    S&P 500 Ends Lower as China-led Global Growth Worries Persist; Fed Eyed By Investing.com

    S&P 500 Ends Lower as China-led Global Growth Worries Persist; Fed Eyed

  • Here is What Hedge Funds Think About Visa Inc (V)
    insidermonkey.com

    Here is What Hedge Funds Think About Visa Inc (V)

    In this article we will check out the progression of hedge fund sentiment towards Visa Inc (NYSE:V) and determine whether it is a good investment right now.

  • Momentum Worldwide launches hybrid experience platform
    prweek.com

    Momentum Worldwide launches hybrid experience platform

    Momentum Worldwide launches hybrid experience platform. From PR Week

  • mRNA- vs. Vektorimfpfung: BioNTech, Moderna & Co. - Experte über die Zukunft von Impfstoffen: "Das Spiel ist vorbei. Es ist mRNA oder...
    finanzen.net

    mRNA- vs. Vektorimfpfung: BioNTech, Moderna & Co. – Experte über die Zukunft von Impfstoffen: “Das Spiel ist vorbei. Es ist mRNA oder nichts”

    Im Kampf gegen die Corona-Pandemie spielen Impfstoffe eine Schlüsselrolle. Dabei werden von verschiedenen Unternehmen unterschiedliche Impfstoffarten genutzt, wie Vektor- oder mRNA-Impfstoffe. Geht es nach dem Gesundheitsexperten Arnaud Bernaert, haben langfristig jedoch lediglich mRNA-Vakzine die Nase vorn. Das steckt dahinter. 21.09.2021

  • US stock indexes wobble a day after biggest drop since May
    startribune.com

    US stock indexes wobble a day after biggest drop since May

    Stock indexes were wobbling between small gains and losses in afternoon trading on Wall Street Tuesday following a sharp pullback a day earlier.

  • Why Cue Health Stock Could Cost You Money After the IPO
    moneymorning.com

    Why Cue Health Stock Could Cost You Money After the IPO

    Cue Health stock became the latest offering on Robinhood IPO Access this week. But here's why the Cue Health IPO could cost retail investors long-term…

  • Hedge Funds Have Never Been This Bullish On Facebook Inc (FB)
    insidermonkey.com

    Hedge Funds Have Never Been This Bullish On Facebook Inc (FB)

    The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database.

  • S&P 500 Rebound Fades on Global Growth Concerns Ahead of Fed Meeting By Investing.com
    investing.com

    S&P 500 Rebound Fades on Global Growth Concerns Ahead of Fed Meeting By Investing.com

    S&P 500 Rebound Fades on Global Growth Concerns Ahead of Fed Meeting

  • COVID-19: J&J says booster dose of its vaccine provides strong immune response
    businesstoday.in

    COVID-19: J&J says booster dose of its vaccine provides strong immune response

    A booster dose of the J&J Covid-19 vaccine further increased antibody responses among study participants who had previously received our vaccine, said Dr. Mathai Mammen, global head of research and development at J&J

  • Shuman, Glenn & Stecker : Investigates Emergent BioSolutions, Inc.
    marketscreener.com

    Shuman, Glenn & Stecker : Investigates Emergent BioSolutions, Inc.

    Shuman, Glenn & Stecker announces that it is investigating potential claims against certain officers and directors of Emergent BioSolutions, Inc. . Emergent is a biopharmaceutical company that… | September 21, 2021

  • J&J: Booster Dose Of Its COVID Shot Prompts Strong Response
    businessworld.in

    J&J: Booster Dose Of Its COVID Shot Prompts Strong Response

    The company is in talks with regulators including the US Food and Drug Administration, the European Medicines Agency and others regarding using booster doses of its vaccine., , johnson and johnson, COVID-19 Vaccine, coronavirus vaccine

  • The Latest: Ramping up rapid COVID-19 tests for home, school
    startribune.com

    The Latest: Ramping up rapid COVID-19 tests for home, school

    President Joe Biden is betting on millions more rapid, at-home tests to help curb the latest deadly wave of the COVID-19 pandemic.

  • Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices
    prnewswire.com

    Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices

    /PRNewswire/ — FinancialNewsMedia.com News Commentary Growing prevalence of cardiovascular disorders (CVDs) globally is anticipated to substantially increase…

  • Stocks making the biggest moves midday: Uber, DraftKings, Seagen, Activision Blizzard and more
    cnbc.com

    Stocks making the biggest moves midday: Uber, DraftKings, Seagen, Activision Blizzard and more

    These are the stocks posting the largest moves in midday trading.

  • Why These 10 Stocks Are on the Move on Tuesday
    insidermonkey.com

    Why These 10 Stocks Are on the Move on Tuesday

    After a major sell off yesterday, the market is relatively calm on Tuesday.

  • FDA Is Expected to Decide on Pfizer Booster Shots on Wednesday
    bloombergquint.com

    FDA Is Expected to Decide on Pfizer Booster Shots on Wednesday

    (Bloomberg) — The Food and Drug Administration is expected to decide as soon as Wednesday on a recommendation for Covid-19 boosters made by Pfizer Inc. and BioNTech SE, two people familiar with the matter said, the latest step in a process that could open the door to extra shots in the coming days.

  • Global Industry Analysts Predicts The World Body Lotions Market To Reach $102.9 Billion By 2026
    thestreet.com

    Global Industry Analysts Predicts The World Body Lotions Market To Reach $102.9 Billion By 2026

    SAN FRANCISCO, Sept. 21, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • HITEC Names Latina CEO Lili Gil Valletta To Prestigious 2022 Top 100 List For Developing Innovative AI-Powered Research Platform CulturIntel
    thestreet.com

    HITEC Names Latina CEO Lili Gil Valletta To Prestigious 2022 Top 100 List For Developing Innovative AI-Powered Research Platform CulturIntel

    DALLAS, Sept. 21, 2021 /PRNewswire/ — HITEC, the premier global leadership organization for senior business and IT technology executives, has named Lili Gil

  • 3 Highly Profitable Low-Risk Stocks to Own
    gurufocus.com

    3 Highly Profitable Low-Risk Stocks to Own

    GuruFocus Article or News written by Nathan Parsh and the topic is about: A look at 3 low-risk names that score well on multiple profitability metrics.

  • Adaptive Biotechnologies’ new HQ: Co-founders show off 100K square-foot space in Seattle
    geekwire.com

    Adaptive Biotechnologies’ new HQ: Co-founders show off 100K square-foot space in Seattle

    After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. The company on Tuesday will cut the ribbon on its new 100…

  • Global Industry Analysts Predicts the World Intimate Hygiene Market to Reach $19.1 Billion by 2026
    prnewswire.com

    Global Industry Analysts Predicts the World Intimate Hygiene Market to Reach $19.1 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Global Pain Management Therapeutics Market Revenue to Hit US$ 81.9 Billion by 2026 - Zion Market Research
    prnewswire.com

    Global Pain Management Therapeutics Market Revenue to Hit US$ 81.9 Billion by 2026 – Zion Market Research

    /PRNewswire/ — According to Zion Market Research Recent Report, the pain management therapeutics industry garnering revenue worth US$ 65.6 Billion in 2019 and…

  • Single-dose vax gives ‘long-lasting’ protection: J&J
    thehindubusinessline.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Johnson & Johnson Aktie

Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.

Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor  MSCI USA  Quality  UCITS  ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Unternehmen aus den Branchen Drogerie & Kosmetik und Wissenschaft